Balance Sheet
Accounts PayablesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent Deferred RevenueCurrent LeasesGoodwillGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityLiabilities from Discontinued OperationsLong-Term Deferred TaxMinority InterestNon-Current AssetsNon-Current DebtOperating LeasesOther Accumulated ExpensesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPreferred SharesPrepaid AssetsProperty, Plant & Equipment (Net)ReceivablesReceivables - NetReceivables - OtherRetained EarningsShareholder's EquityShort term DebtTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current LiabilitiesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

AdaptHealth (AHCO) Receivables - Other (2018 - 2025)

Historic Receivables - Other for AdaptHealth (AHCO) over the last 8 years, with Q3 2025 value amounting to $32.2 million.

  • AdaptHealth's Receivables - Other rose 769.23% to $32.2 million in Q3 2025 from the same period last year, while for Sep 2025 it was $32.2 million, marking a year-over-year increase of 769.23%. This contributed to the annual value of $41.6 million for FY2024, which is 3918.13% down from last year.
  • Per AdaptHealth's latest filing, its Receivables - Other stood at $32.2 million for Q3 2025, which was up 769.23% from $33.2 million recorded in Q2 2025.
  • In the past 5 years, AdaptHealth's Receivables - Other ranged from a high of $68.4 million in Q4 2023 and a low of $13.8 million during Q1 2021
  • Moreover, its 5-year median value for Receivables - Other was $31.9 million (2024), whereas its average is $31.9 million.
  • In the last 5 years, AdaptHealth's Receivables - Other skyrocketed by 9519.65% in 2023 and then plummeted by 3918.13% in 2024.
  • Quarter analysis of 5 years shows AdaptHealth's Receivables - Other stood at $23.8 million in 2021, then soared by 62.18% to $38.6 million in 2022, then soared by 77.2% to $68.4 million in 2023, then tumbled by 39.18% to $41.6 million in 2024, then decreased by 22.6% to $32.2 million in 2025.
  • Its Receivables - Other stands at $32.2 million for Q3 2025, versus $33.2 million for Q2 2025 and $38.4 million for Q1 2025.